Jon Van Pelt is the VP/GM of Cytiva’s Bioprocess Single Use & Enterprise Solutions business where oversees a team driven to bring transformative medicines to patients. From vaccines to monoclonal antibodies, Jon’s team delivers innovative bioprocess solutions that advance and accelerate the manufacture of novel therapeutics.
Jon joined Cytiva when it was part of GE Healthcare Life Sciences and has held roles on the Commercial and Enterprise teams before assuming his current role. Prior to joining Cytiva, he spent more than two decades at General Electric in various account management, product management, commercial operations and business integration roles.
After graduating from the University of Kentucky with a bachelor’s degree, Jon earned his MBA from Saint Louis University.